| scholarly article | Q13442814 |
| P356 | DOI | 10.1128/IAI.73.2.1006-1013.2005 |
| P8608 | Fatcat ID | release_2qcgftyhzna77fehplx26io5x4 |
| P932 | PMC publication ID | 547096 |
| P698 | PubMed publication ID | 15664944 |
| P50 | author | Jacquelyn S Sampson | Q106930492 |
| Edwin W Ades | Q106930501 | ||
| David E. Briles | Q112394397 | ||
| P2093 | author name string | James C Paton | |
| James W Lillard | |||
| Shailesh Singh | |||
| Udai P Singh | |||
| Susan K Hollingshead | |||
| Ravichandran Palaniappan | |||
| Senthil Kumar K Sakthivel | |||
| P2860 | cites work | Lymphotactin acts as an innate mucosal adjuvant | Q28588021 |
| Selection of an immunogenic and protective epitope of the PsaA protein of Streptococcus pneumoniae using a phage display library | Q30859014 | ||
| Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection. | Q33552360 | ||
| Confirmation of psaA in all 90 serotypes of Streptococcus pneumoniae by PCR and potential of this assay for identification and diagnosis | Q33974979 | ||
| Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae. | Q34001813 | ||
| The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia | Q34002787 | ||
| Host cellular immune response to pneumococcal lung infection in mice. | Q34003173 | ||
| Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae | Q34003306 | ||
| Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA. | Q34009174 | ||
| Streptococcus pneumoniae serotype 4 outbreak in a home for the aged: report and review of recent outbreaks | Q34088193 | ||
| Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae | Q34121334 | ||
| Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia | Q34433776 | ||
| Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance | Q34547849 | ||
| Mechanisms for induction of acquired host immunity by neutrophil peptide defensins | Q34835899 | ||
| Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae | Q35105898 | ||
| Effect of Streptococcus pneumoniae on human respiratory epithelium in vitro | Q35111190 | ||
| Increased protection against pneumococcal disease by mucosal administration of conjugate vaccine plus interleukin-12. | Q35165637 | ||
| Nasopharyngeal antibodies to pneumococcal pneumolysin in children with acute otitis media | Q35225029 | ||
| Sequence heterogeneity of PsaA, a 37-kilodalton putative adhesin essential for virulence of Streptococcus pneumoniae | Q35532255 | ||
| Role of gamma interferon in the pathogenesis of bacteremic pneumococcal pneumonia | Q35551768 | ||
| Mouse antibody to phosphocholine can protect mice from infection with mouse-virulent human isolates of Streptococcus pneumoniae | Q36945140 | ||
| Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae | Q36953957 | ||
| Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide | Q36966367 | ||
| PspC, a pneumococcal surface protein, binds human factor H. | Q39520120 | ||
| Role of tumor necrosis factor alpha in the host response of mice to bacteremia caused by pneumolysin-deficient Streptococcus pneumoniae. | Q39570137 | ||
| Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization | Q39912979 | ||
| A pilot study of the predictive value of plasma tumor necrosis factor alpha and interleukin 1 beta for Streptococcus pneumoniae bacteremia in febrile children | Q40658787 | ||
| Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae | Q41080026 | ||
| The contribution of pneumolysin to the pathogenicity of Streptococcus pneumoniae | Q41161717 | ||
| Pneumococcal nasopharyngeal carriage in children following heptavalent pneumococcal conjugate vaccination in infancy. | Q42123701 | ||
| The immune response to pneumococcal proteins during experimental human carriage | Q42944608 | ||
| Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media | Q44836024 | ||
| SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component | Q48043357 | ||
| The hemolytic and complement-activating properties of pneumolysin do not contribute individually to virulence in a pneumococcal bacteremia model. | Q50928211 | ||
| Streptococcus pneumoniae evades complement attack and opsonophagocytosis by expressing the pspC locus-encoded Hic protein that binds to short consensus repeats 8-11 of factor H. | Q51728887 | ||
| Recombinant human interleukin 6 (rhIL-6) promotes the terminal differentiation of in vivo-activated human B cells into antibody-secreting cells | Q68183490 | ||
| Requirement for lymphocyte-macrophage interaction in the response of mouse spleen cultures to pneumococcal polysaccharide | Q68759080 | ||
| Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine | Q71825810 | ||
| Virulence of Streptococcus pneumoniae in mice: a standardized method for preparation and frozen storage of the experimental bacterial inoculum | Q71980011 | ||
| Cytokines in experimental otitis media with effusion | Q72758772 | ||
| Pneumococcal surface adhesin A antibody concentration in serum and nasopharyngeal carriage of Streptococcus pneumoniae in young African infants | Q73067782 | ||
| Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA | Q73166608 | ||
| Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae | Q73188461 | ||
| Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers | Q73509127 | ||
| Establishment of a Streptococcus pneumoniae nasopharyngeal colonization model in adult mice | Q73661394 | ||
| Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae | Q73688169 | ||
| Modulation of cytokines and chemokines, limited pulmonary vascular bed permeability, and prevention of septicemia and death with ceftriaxone and interleukin-10 in pneumococcal pneumonia | Q74296085 | ||
| Do antibodies to pneumococcal surface adhesin a prevent pneumococcal involvement in acute otitis media? | Q74333001 | ||
| The genes encoding virulence-associated proteins and the capsule of Streptococcus pneumoniae are upregulated and differentially expressed in vivo | Q74420664 | ||
| Expression, purification and preliminary X-ray crystallographic analysis of PsaA, a putative metal-transporter protein of Streptococcus pneumoniae | Q74630104 | ||
| Interleukin-10 enhances immune responses to pneumococcal polysaccharides and sheep erythrocytes in young and aged mice | Q78088098 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1006-1013 | |
| P577 | publication date | 2005-02-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Differential PsaA-, PspA-, PspC-, and PdB-specific immune responses in a mouse model of pneumococcal carriage | |
| P478 | volume | 73 |
| Q33802029 | A longitudinal study of natural antibody development to pneumococcal surface protein A families 1 and 2 in Papua New Guinean Highland children: a cohort study |
| Q28274748 | Addiction of Hypertransformable Pneumococcal Isolates to Natural Transformation for In Vivo Fitness and Virulence |
| Q37185085 | Asthma and antibodies to pneumococcal virulence proteins |
| Q35717991 | CCL5-independent helper T lymphocyte responses to immuno-dominant pneumococcal surface protein A epitopes |
| Q36266282 | CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells |
| Q64060344 | Complete Genome Sequence of Streptococcus pneumoniae Serotype 19F Strain EF3030 |
| Q43706274 | Concomitant administration of recombinant PsaA and PCV7 reduces Streptococcus pneumoniae serotype 19A colonization in a murine model |
| Q37622565 | Cord blood Streptococcus pneumoniae-specific cellular immune responses predict early pneumococcal carriage in high-risk infants in Papua New Guinea. |
| Q80380466 | Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP |
| Q33877075 | Functional characterization of the IlpA protein of Vibrio vulnificus as an adhesin and its role in bacterial pathogenesis |
| Q35073127 | Genetic diversity of PspA types among nasopharyngeal isolates collected during an ongoing surveillance study of children in Brazil |
| Q33535951 | Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A. |
| Q39620052 | Intranasal immunization with autolysin (LytA) in mice model induced protection against five prevalent Streptococcus pneumoniae serotypes in China |
| Q34145626 | Lipoproteins of Bacterial Pathogens |
| Q89068515 | Novel Immunoprotective Proteins of Streptococcus pneumoniae Identified by Opsonophagocytosis Killing Screen |
| Q42083281 | Pneumococcal PspA and PspC proteins: potential vaccine candidates for experimental otitis media |
| Q36211192 | Pneumococcal interactions with epithelial cells are crucial for optimal biofilm formation and colonization in vitro and in vivo. |
| Q37279975 | Pneumococcal surface adhesin A (PsaA): a review |
| Q43783758 | Prediction and characterization of helper T-cell epitopes from pneumococcal surface adhesin A. |
| Q37699512 | Residence of Streptococcus pneumoniae and Moraxella catarrhalis within polymicrobial biofilm promotes antibiotic resistance and bacterial persistence in vivo |
| Q40240545 | Self-assembled particulate PsaA as vaccine against Streptococcus pneumoniae infection |
| Q43745716 | Splenic autotransplantation restores IL-17 production and antibody response to Streptococcus pneumoniae in splenectomized mice |
| Q28082440 | Streptococcus pneumoniae biofilm formation and dispersion during colonization and disease |
| Q47981250 | Systemic immunization with rPotD reduces Streptococcus pneumoniae nasopharyngeal colonization in mice |
| Q53083052 | Th17/Th1 biased immunity to the pneumococcal proteins PcsB, StkP and PsaA in adults of different age. |
Search more.